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Abstract 
Background: Randomised controlled Trials (RCTs) investigating Complementary and 
Alternative Medicine (CAM) for pregnancy-related issues have encountered issues with 
recruitment and attrition. Little is known about the cause of these issues.  
 
 Methods: Data was gathered from an antenatal CAM randomised controlled trial. During foetal 
anomaly appointments, women meeting inclusion criteria were invited to participate in the trial. 
Numbers of women invited and eligible were recorded. Reasons for non-interest were noted 
and analysed. Focus groups exploring trial experience of participants were also conducted. 
 
Findings: Of the 428 women invited to participate, 376 were eligible and just under a quarter 
participated. Reasons for non-participation included concerns about CAM and lack of interest 
in participation in research. Other factors negatively affecting recruitment included: recruitment 
timing, competition for participants; limited support from staff and inadequate trial promotion. 
Factors encouraging recruitment included being interested in research and seeking pain relief. 
Reasons for dropping out were time constraints, travel issues, work commitments and 
pregnancy issues. Several women in the sham and usual care group dropped out due to 
dissatisfaction with treatment allocation.  
Conclusion: CAM Researchers must explore problems encountered with recruitment and 
attrition so that evidence-based implementation strategies to address the issues can be 
developed. 
. 
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Introduction 
During pregnancy women often suffer a range of complaints such as nausea, vomiting, 
heartburn and low back and/ or pelvic pain (LBPP), and many women turn to Complementary 
and Alternative Medicine (CAM) to alleviate these symptoms [1,2,3,4]. The percentage of 
women using CAM during pregnancy has been reported to be as high as 87% [5]. However, 
despite the high percentage of pregnant women using CAM, there are surprisingly few well-
designed randomised controlled trials (RCTs) which have assessed the effectiveness of CAM 
interventions during pregnancy and many of the existing RCTs have encountered difficulties 
with recruitment and attrition [6,7,8,9,10,11]. 
CAM trials with pregnant women often have small sample sizes and this is likely related to 
issues with recruitment. Mollart [6] recruited just 96 pregnant women during a two-year period 
to an RCT investigating the effectiveness of reflexology for ankle oedema. In addition to this, in 
a pilot RCT investigating the effectiveness of chiropractic treatment and neuro emotional 
technique compared to exercise for pregnancy low back pain, researchers recruited just 57 
pregnant women in 20 months. Kimber et al. [10] took 14 months to recruit 90 pregnant women 
to an RCT investigating massage for labour pain. Small sample sizes such as these affect the 
inferential capacity to make firm conclusions on the effectiveness of these CAM interventions 
for pregnancy related issues. Recruitment of pregnant women into trials may not be an issue 
isolated to CAM trials, as other types of trials with pregnant women have struggled with 
recruitment. For example, recruitment rates to dietary and exercise trials with pregnant women 
have reported recruitment rates to be between 19-24% [12, 13, 14].  
High attrition of study participants has been an issue that has plagued many CAM trials with 
pregnant women. In RCTs short term attrition rates of greater than 20% are considered 
unacceptable and may introduce bias into such trials [15]. Moreover, attrition rates greater than 
30% in a specific arm of a trial indicate significant flaws exist in the study and the findings of 
such studies should be reviewed and interpreted with caution [15]. Overall attrition rates in CAM 
trials with pregnant women frequently exceed 20%. Kvorning et al. [11] investigated 
acupuncture for LBPP during pregnancy and reported an overall dropout rate of 28%. Similarly 
Lund et al. [7] investigated acupuncture for pelvic pain in pregnancy and reported an overall 
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dropout rate of 32%. However, other non-CAM trials with pregnant women have reported more 
acceptable overall attrition rates. For example an RCT investigating the effectiveness of the 
Bellybra support garment compared to a Tubigrip garment (control) for pregnancy back pain, 
attrition was much more reasonably at 18% [16].  Further to overall attrition rates, CAM trials 
with pregnant women have also experienced high attrition rates in comparison groups. For 
example, Wendenberg et al. [17] investigated the effectiveness of acupuncture for pregnancy 
LBPP compared to physiotherapy. There was a 40% attrition rate in the physiotherapy group 
and 0% attrition rate in the acupuncture group. The difficulty of blinding participants in CAM 
trials may be a factor associated with the high attrition issues discussed [18].  
The poor evidence base for CAM use during pregnancy is concerning given the high 
percentage of women reportedly using these treatments. Therefore, improving the evidence 
base for CAM use during pregnancy needs to be prioritised, to equip maternity care 
professionals with the knowledge to provide evidence-based advice and support to pregnant 
women on the effectiveness and safety of using CAM interventions during pregnancy. In order 
to improve the evidence base for CAM, pressure has been put on research teams to conduct 
more RCTs in the area, as RCTs are recognised as the gold standard for assessing the 
effectiveness of interventions [19]. However, the suitability of using an RCT for assessing the 
effectiveness of CAM has been questioned given the many issues CAM RCTs have been 
shown to encounter in relation to recruitment, attrition, blinding and disagreement on whether 
CAM treatments in RCT’s should be standardised or should they follow a pragmatic approach 
as used clinical practice [20]. However, despite the questions raised around the suitability of 
RCTs to assess CAM effectiveness it would seem that given the current focus on evidence –
informed practice the emphasis on implementing RCTs to assess CAM effectiveness is set to 
continue. Therefore, exploring factors affecting pregnant women’s participation and drop-out in 
a CAM trial may aid better recruitment and reduce attrition to such studies in the future and 
ultimately may lead to a larger, more robust evidence base for CAM use during pregnancy 
which is desperately lacking. 
The evidence base for the effectiveness of reflexology in pregnancy is particularly sparse and 
of dubious methodological quality. However, reflexology continues to be offered to pregnant 
women across the UK within maternity units and is one of the four most frequently used forms 
of CAM in these units [21]. Reflexology is promoted in these settings for managing a wide range 
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of pregnancy-related issues including, labour preparation and managing pregnancy related 
symptoms such as back and pelvic pain. Given the use of reflexology in maternity settings in 
the absence of any robust evidence of effectiveness for pregnancy related complaints it was 
deemed important to explore the effectiveness of reflexology for pregnancy related issues. The 
effectiveness of reflexology for pregnancy low back and pelvic was explored due to the fact 
reflexology had been shown to be helpful for non-specific low back pain in the general 
population [22]. 
Aim 
This paper aims to explore the factors which affect recruitment and attrition in a pilot RCT 
investigating reflexology for pregnancy LBPP. 
 
Methods 
This paper presents on secondary data from “The CAM in Pregnancy Trial”, 
(ISRCTN26607527) a pilot RCT investigating the effectiveness of reflexology for pregnancy 
LBPP, as well as reporting on the findings from focus groups which were conducted with The 
CAM in Pregnancy Trial participants after their participation in the trial. 
 Ethical approval 
This research received full ethical approval from the Office of Research Ethics for Northern 
Ireland in July 2012. 
RCT description 
The pilot RCT was designed and implemented aiming to determine if it was possible to conduct 
an RCT investigating the effectiveness of reflexology as an addition to usual care for pregnancy 
LBPP  
Women were randomly allocated to one of three groups, namely reflexology plus usual care, 
footbath (as a sham intervention) plus usual care or usual care only. Reflexology participant’s 
received six weeks of reflexology, footbath participants received six weeks of footbath 
treatments and women in usual care received no additional treatment. The primary outcome 
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measure was the frequency and intensity of their pain, which were assessed before and after 
the six-week study period. Secondary outcome measures were back specific function, mobility 
and anxiety. 
Midwives Briefing session 
Midwives were acting as the gatekeepers to the study population, therefore it was considered 
essential that they were given an initial briefing about the study. In May 2012 a briefing 
session was given to the ante-natal midwifery team at the Maternity Unit hosting the trial. The 
briefing session aimed to inform midwives about the trial, its purpose, and the inclusion and 
exclusion criteria (table 1) before the trial began in July 2012. Midwives were provided with a 
health professional information sheet detailing information on all aspects of the study, and 
additional copies were placed in consultation rooms along with study posters to prompt 
midwives to discuss study participation with eligible women. Further to this, as and when new 
midwives joined the ante-natal midwifery team the researchers made efforts to introduce 
themselves and the study providing them with a Health Professional information sheet. 
 
Recruitment 
Over a 14-month period, pregnant women were invited to take part in the present trial at a 
routine foetal anomaly scan (normally 20-22 weeks’ gestation) in a large urban maternity unit, 
with approximately 4000 births annually. As mentioned ante-natal clinic midwives acted as the 
gate-keeper for the trial, introducing the study to potentially eligible pregnant women and asking 
for women’s permission for a researcher to provide further verbal and written information on 
The CAM in Pregnancy Trial. If women were happy to receive further information on the trial 
from the researcher, the researcher joined the ante-natal appointment. At this point women who 
expressed an interest in participation were provided with a participant information sheet. The 
process of assessing eligibility and randomisation is described elsewhere [9]. Inclusion and 
exclusion criteria for The CAM in Pregnancy Trial are detailed in table 1.  
Women with a DVT, gestational diabetes or Placenta Previa were excluded as complementary 
therapies are contra-indicated in several health conditions.  Women currently using CAM 
therapies were also excluded to remove possible confounding variables to investigating the 
effectiveness of reflexology for pregnancy-related low back and pelvic pain.  
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Table 1 Inclusion and exclusion criteria for The CAM in Pregnancy Trial 
Inclusion criteria Exclusion criteria 
First time pregnant women Women pregnant with more than 
one baby 
≥18 years of age Smokers 
Presence of low back pain and/or 
pelvic pain 
Women with neurological 
diseases 
26-29 weeks gestation Deep Vein Thrombosis (DVT) 
sufferers 
Able to understand written and 
verbal English 
Fungal foot infections or verrucae 
 Currently using CAM therapies 
 Placenta Previa Grade 3 or 4 
 Already participating in a research 
study 
 Any serious spinal pathology  e.g. 
cancer, cauda equina, infection in 
the spine 
 Previous road traffic accident 
 Previous surgery to the hip, back 
or pelvic region 
 Inflammatory arthritis, e.g. 
rheumatoid arthritis 
 Diabetes/Gestational diabetes 
 Cardiac related problems 
 Women whom the midwife deems 
unable to participate 
 
Recruitment data  
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The research team gathered data on the number invited to participate and the number of 
women eligible. This information was analysed to provide percentage totals such as the 
percentage of eligible women that participated. The research team took written notes on 
reasons provided for non-participation. These reasons were compiled and analysed using 
thematic analysis.  
Attrition data 
Data on attrition rates was generated from “The CAM in Pregnancy Trial”. Reasons for dropping 
out (where provided) were gathered and analysed using thematic analysis.  
Focus groups 
Focus groups were conducted with women who had completed “The CAM in Pregnancy Trial”. 
The primary aim of these focus groups was to explore women’s experience of low back and 
pelvic pain during pregnancy. However, a secondary aim of the focus groups was to explore 
women’s experience of being part of “The CAM in Pregnancy Trial”. Women were specifically 
questioned about the positive and negative aspects of the trial from their perspective. Focus 
group findings were analysed used the Newell and Burnard framework for thematic analysis 
[23]. Further detail on the methodology and results from these focus groups is reported 
elsewhere [24].  
Results 
Recruitment 
Recruitment took place between July 2012 and September 2013. Of the 428 primigravada 
women who were invited to take part in the pilot RCT, 52 did not meet the inclusion/ exclusion 
criteria identified for this study. The major factor for exclusion from the pilot RCT was that the 
women were already participating in another research study at that time (n=38). This had been 
identified as an exclusion criteria due to the burden participating in two concurrent research 
studies would have placed on the participant. After exclusions this left 376 potentially eligible 
women to participate in the pilot RCT.   
Of the eligible women 70% (n=262) expressed an interest in participating in The CAM in 
Pregnancy Trial and therefore were provided with a participant information sheet. The 
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remaining 30% (n=114) of eligible women indicated from the outset that they did not wish to 
take part in The CAM in Pregnancy Trial or receive a participant information sheet. Of the 
eligible women who declined to participate at the point of recruitment 32% (n=37/114) provided 
a reason and this was mainly due to a lack of interest in research (table 2). Unfortunately, as it 
was not part of the study protocol to ask women why they refused to participate in the trial we 
were unable to obtain a reason for refusal to participate from the remaining 68% (n=77/114) of 
eligible women who declined the invitation immediately after being invited to participate.  
Table 2: Reasons provided for declining invitation to participate in The CAM in Pregnancy Trial 
at the point of recruitment 
Reason Number of women (n=37) 
Not interested in taking part in research 21(57%) 
 
Concerned about using CAM in 
pregnancy 
8 (22%) 
 
Dislike having feet touched 
4 (11%) 
 
Travel issues 
2 (5%) 
Pain so bad would be unable to make 
weekly appointments for the study 
 
2 (5%) 
 
Attrition  
64/ 90 (83%) of women randomised completed the six-week intervention period. A variety of 
reasons for dropping out of the six-week study period were provided. The most common being 
medical reasons, work commitments and unhappy with treatment allocation. Drop-out rates 
were highest in the footbath group and lowest in the usual care only group (table 3).  
Table 3: Reasons provided by participants for dropping out of The CAM in Pregnancy Trial 
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Reflexology drop outs(n=6) Footbath drop outs (n=15) Usual care drop outs (n=5) 
1= Pre-eclampsia 
1= travel issues 
2= no longer have pain 
1= verruca 
1=unknown 
 
1=preeclampsia 
3=work commitments 
3=unhappy with treatment 
allocation (wanted 
reflexology) 
1=travel issues 
1=personal reasons 
1=feeling too tired 
5=unknown 
 
1=preeclampsia 
1=unhappy with treatment 
allocation (wanted 
reflexology) 
3=unknown 
 
Focus group findings 
The focus groups were attended by 14 women. Participants had a mean age of 33 and all had 
completed the six week study period of The CAM in Pregnancy Trial; eight were in the 
reflexology group, two were in the usual care group and four in the footbath group. Most (13/14) 
of the participants had used CAM previously. Thematic analysis revealed three major themes 
in relation to women’s experiences of the trial each with two subthemes (table 4).  
 
 
 
 
 
 
 
Table 4: Themes describing women’s experiences of participating in The CAM in Pregnancy 
Trial 
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Main theme Sub-theme 
Factors negatively affecting recruitment -Lack of awareness and support for the  
trial from maternity staff 
-Poor visual and verbal promotion of the 
trial 
 
Factors positively affecting recruitment -Interested or experienced research 
-Desire for pain relief 
 
Factors negatively affecting attrition -Maternity staff un-blinding the trial 
-Footbath wasn’t helping pain 
 
The participant who provided a particular quote in the focus group will be coded as follows: 
Participant identification number, age and intervention group.  The abbreviations in table 5 
below will be used. 
Table 5: Abbreviations for focus group quotations 
Term  Abbreviation 
Participant number PN 
Reflexology  R 
Footbath FB 
Usual care UC 
 
 
Subtheme 1: Factors negatively affecting recruitment  
 
Lack of awareness and support for the trial from maternity staff 
Some women identified an issue that health professionals did not know that the study was 
happening and that other health professionals were not supportive of the trial: 
“My own community midwife was like…ah…I wish they had of told me about that…she 
was raging.She said I wish I had been told about that,” (PN14, 30 R) 
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“Whenever I was with my midwife they asked about the sticker on the front of my green 
folder and they had never heard of the study before,” (PN13, 27 FB) 
 
“No offence to some of the midwives and I know some of them they were a bit blasé 
about it (The CAM in Pregnancy Trial),” (PN3, 34 R) 
 
“I think if that if they (Midwifery staff)  were more...mmm more versed or had a wee bit 
more knowledge they might be a bit more proactive,”(PN3,34 R) 
Poor verbal and visual promotion of the trial 
The visual and verbal promotion of the study may have been a factor for the slow recruitment 
to the trial: 
 
“I believe the posters were already up at this stage but I missed them…I must have 
missed them…they didn’t catch my eye,” (P7, 32 R) 
 
“If there was more detail in the poster,” (PN3, 34 R) 
 
“It wasn’t mentioned to me, at the 20-week scan and I mentioned to them about the 
pelvic pain,” (PN7, 32 R). 
 
Sub-theme 2: Factors positively affecting recruitment 
Interested or experienced in research  
Women reported being motivated to participate in the trial due to having interest or experience 
in research: 
 
“Well I think research is important… I would be interested in research,” (PN2, 32 FB) 
 
“I just thought research is really important… especially if there is loads of people in the future 
that it helps…I think you have go to start doing things like that,” (PN4, 30 UC) 
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 “I am a research scientist …so I just wanted to be able to take part…to give back in some 
way…am I appreciate how hard it can be to get numbers,” (PN7, 32 R). 
 
Desire for symptom relief 
 
While some women reported being motivated to participate in the trial for its research potential, 
others narratives indicated that the possibility of obtaining pain relief was the factor which 
motivated their participation. For some women it was the non-pharmacological nature of CAM 
that attracted them to participate in the trial: 
 
“So as to see if it could be determined if reflexology was going to help…was going to be helpful 
for the pelvic pain..there was nothing helping me and there was nothing else on offer,” (PN11, 
36, UC) 
 
“It was probably a bit more selfish …I would have taken anything offered to me to be honest… 
I wasn’t really thinking beyond that,” (PN12, 30, R) 
 
“I am a great believe in holistic therapies… and I am not a big fan of taking pain killers… I 
think… I will be very honest I had a miscarriage before I had XXXX and didn’t want to take any 
additional medication… in case it had an effect,” (PN3, 34 R) 
Subtheme 3: Factors negatively affecting attrition 
Maternity staff un-blinding the trial 
Comments suggested that un-blinding of the active intervention had occurred. In several 
instances the midwife who introduced the study to them indicated that reflexology was the 
treatment under investigation. Women reported on how midwives referred to the study as a 
“Reflexology study” or “Free reflexology”: 
“I was told it was free reflexology and that was how it was sold to me,” (PN10, 34 R 
LBPP) 
 “I think we could have got more information about each of treatment groups…I think I 
was led into believing it was reflexology,” (PN9, 35 FB) 
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“I was told it was reflexology and it would help your back pain the midwife didn’t actually 
say to me at that point there are three options,” (PN8, 35 UC) 
 
Footbath wasn’t helping pain 
Attrition in the footbath may have been related to the fact it wasn’t helping some women’s pain: 
 
“I found it relaxing but not for pain,” (PN9, 35 FB) 
 
“I think although it was great to get that time to myself…but it just wasn’t helping my 
pelvic pain…and the thought of getting in and out of the car another time each week 
made me think what’s the point if it’s not helping my pain,” (PN2, 32 FB) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Discussion 
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Recruitment was slower than anticipated for The CAM in Pregnancy Trial given that the trial 
was recruiting pregnant women with low back and pelvic pain, conditions highly prevalent in 
this population [25]. It was originally anticipated that recruitment of participants would take 
approximately one year. However, due to difficulties identifying suitable candidates an 
additional two months was added to the recruitment period. Campbell et al. [26] explored rates 
of participation in RCTs and found that one third of RCTs had to extend the recruitment time-
frame to obtain the necessary sample size.  
It is difficult to compare recruitment rates for The CAM in Pregnancy Trial and other CAM trials 
with pregnant women due to authors failing to report on the numbers of women invited to 
participate, assessed for eligibility and the numbers of women that participated. There is a 
tendency in CAM trials to report only on the numbers of women that actually participated. 
However, when comparisons of recruitment rates are made with The CAM in Pregnancy Trial 
and with other CAM studies with pregnant women that reported detailed recruitment 
information, it appears recruitment to The CAM in pregnancy trial (24%) was within normal 
ranges. For example in a three armed pilot RCT investigating massage therapy for reducing 
pain in labour, researchers recruited 21% of eligible women [10].  
Recruitment rates to The CAM in Pregnancy Trial were also very similar to other intervention 
trials with pregnant women possibly suggesting that recruitment issues experienced in the 
present trial may be partly related to the population under investigation, a population often 
underrepresented in clinical trials. For example in an RCT investigating the effectiveness of a 
dietary and physical activity intervention for preventing gestational diabetes, Luoto et al. [14] 
recruited 19% of eligible women. Currie et al. [13] highlighted that pregnant women are a 
challenging population to engage in public health interventions research, with issues such as 
work commitments and pregnancy conditions being common reasons for non-participation in 
studies. Work commitments and pregnancy conditions were issues in the present study in 
relation to attrition. Participation in the present trial initiated from approximately 27 weeks 
gestation, which is the beginning of the third trimester of pregnancy, a time when pregnant 
women often suffer tiredness. Therefore, it is important to implement strategies where possible 
to reduce the burden of study participation on participants for example co-ordinating study 
appointments to take place at the same time as ante-natal appointments. 
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The issues identified with recruitment and attrition in the present trial are a mixture of issues 
with pregnant women’s’ participation in trials in general and pregnant women’s participation to 
CAM trials. For example recruitment timing is important for all studies with pregnant women, as 
insensitive or untimely invitations to participate in pregnancy trials may reduce recruitment 
rates. Recruitment to The CAM in pregnancy may have been too early in pregnancy, with 
recruitment taking place second trimester. LBPP is more prevalent in the third trimester of 
pregnancy and reaches peak intensity and interference at this time [27, 28]. Therefore, trial 
information provided to women not experiencing pain at this time would have been of little 
relevance to them. Women’s decision to participate in a clinical trial during pregnancy is often 
guided by possible benefits to maternal and foetal health/ well-being, but at 20-22 weeks many 
women do not have low back or pelvic pain so therefore there would be little incentive for them 
to participate [29, 30]. Prompting women again about participation in the study at an ante-natal 
clinic appointment in the third trimester could have increased recruitment. Furthermore, 
recruitment of participants was at the foetal anomaly scan which may have been an issue. 
Some women need to have their foetal anomaly scan repeated due to the foetus being in a 
sub-optimal position, which can be distressing. Therefore, these women may not have taken 
on board the information on The CAM in Pregnancy Trial provided at the time. 
 The recruitment of those not currently using CAM presents an issue in relation to significantly 
reducing the pool of eligible women particularly as CAM in very popular with pregnant women 
for pain conditions like pregnancy-LBPP [31]. It is highly possible many of the women invited to 
participate may have been using CAM and thus may not have stepped forward to take part after 
being informed by the midwife and/ or researcher that this was an exclusion to trial participation. 
Furthermore, the exclusion of current CAM users could be seen as being possibly bias, as 
exclusion of current CAM users may have meant that participants had little knowledge or 
interest in CAM. However, in an attempt to minimise this possible bias the research team 
ensured that previous CAM experience was not an exclusion criteria.  
Another issue which may affect recruitment of pregnant women to trials in general is competition 
for study participants from other trials being conducted simultaneously. The APP trial was also 
recruiting healthy first time mothers at the same time as the present trial but was recruiting 
women earlier at their booking appointment at eight-14 weeks’ gestation. This meant that the 
recruitment point for The CAM in Pregnancy Trial, some women were already participating in 
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The APP Trial which reduced the number of eligible participants. Competition for participants 
has previously been reported as a barrier to effective recruitment into research studies [32]. 
Better planning of recruitment timing and the use of a multi-centred approach to recruitment 
may have improved recruitment rates of the trial. 
Focus group findings indicated that not all eligible women were informed about the study 
indicating that discussions about the trial with eligible women were ad hoc. The reasons why 
midwives did not to inform all eligible women about the study are unclear. Non-recruitment of 
potentially eligible women by gatekeepers such as maternity health professionals would appear 
to be an issue more generally for trials with pregnant women. Research has shown that these 
health professionals frequently report lack of time, lack of awareness of on-going trials and lack 
of knowledge of trial inclusion criteria as reasons for non-recruitment of pregnant women into 
research studies [32, 33]. Midwives often change department in maternity units and so newer 
midwives to departments where trials are being conducted may not be aware that studies are 
taking place. This may be due to their absence at study information sessions or due to study 
information being put in inaccessible locations such as under other paperwork as identified by 
Stuart et al. [33]. This also happened in  the current study where trial information sheets for 
health professionals were put in a locked cabinet and so were not easily accessible to staff. 
Maternity staff may need regular briefing sessions about on-going research projects to ensure 
that all staff, including those new to the department, are fully aware of current studies and their 
inclusion/ exclusion criteria. Regular briefing sessions may also provide an opportunity for 
researchers to provide details on recruitment rates which may encourage staff to be more 
proactive with introducing the study to eligible women. Focus group comments from women 
also suggested that there was a lack of support from some midwifery staff when women 
mentioned that they were taking part in The CAM in Pregnancy Trial. Provision of regular 
briefing sessions on CAM trials with pregnant women to maternity professionals may be of even 
greater importance than other trials with pregnant women given that midwives attitudes towards 
CAM use in pregnancy can vary from some midwives being over enthusiastic about its benefits 
to others being totally dismissive of its potential for effectiveness [34,35]. Therefore, it is 
possible that midwives own personal attitudes towards CAM may have affected recruitment 
rates.  
18 
 
Another issue which may have affected recruitment was the visual promotion of the trial; and 
this may be an issue for poor recruitment rates to pregnancy trials in general. Women discussed 
during the focus group how they did not see the poster in the hospital and others thought that 
the poster didn’t give an accurate reflection of what the pilot RCT involved. During The CAM in 
Pregnancy Trial only one A3 poster advertising the study was on display for most of the 14-
month recruitment period. Originally there were 12 study posters on display throughout the 
ante-natal clinic waiting area but for unknown reasons an Obstetrician removed all but one 
poster shortly after the trial began recruiting. It could be speculated that this may be related to 
the personal views of this Obstetrician. Research with maternity professionals has shown that 
midwives and obstetricians have contrasting opinions on the effectiveness of CAM[37]. A 
survey by Gaffney and Smith [37] reported that 88 (65%) midwives agreed that alternative 
therapies effective in encouraging the body’s natural healing ability, yet only 13 (19%) 
obstetricians agreed with this statement and few would recommend CAM. In contrast to this, 
Obstetricians appear more supportive of medications during pregnancy as opposed to 
alternative medicines for pain. For example a survey of obstetricians found that that 80% felt 
paracetamol was appropriate to recommend during pregnancy for dental pain [36].Better use 
of social media such as Facebook and Twitter may have been useful for increasing recruitment 
rates. Shere et al. [38] found that the addition of these forms of social media increased 
recruitment of pregnant women into an RCT investigating folic acid by 12 fold compared to 
traditional sources of promotion such as posters, leaflets and brochures.  
 
A specific issue related to recruiting pregnant women to CAM trials is “Safety Concerns”, which 
are understandably given that the majority of CAM is not provided by the NHS by rather is 
accessed privately [39].Tooher et al. [32] suggests that perception of risk is an important issue 
when pregnant women are making decisions about trial participation. If the pregnant women’s 
perception of risk is too high she will ultimately refuse to take part in an RCT [29]. Research 
has shown that pregnant women generally put more priority on the health of their baby rather 
than their own health [30].  While only eight women actually reported concern about the safety 
of reflexology during pregnancy as a reason for declining the invite to participate in the present 
trial, many other women questioned the researchers at the initial recruitment about the safety 
of reflexology in relation to its ability to induce labour. Concerns about reflexology are 
unsurprising given the lack of clarity about the role of reflexology in labour induction and the 
fact that midwives recommend the use of reflexology for induction of labour [40, 41]. In these 
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circumstances it is important that maternity staff make it clear to women that there is no sound 
scientific-evidence that reflexology stimulates labour and that the few studies that have found 
an impact of reflexology on expediting labour are of low quality and employed specific 
reflexology techniques which would never be performed in studies assessing reflexology for 
other pregnancy-related issues. 
During recruitment it was observed that women frequently looked towards the midwife for 
reassurance that reflexology was safe to use during pregnancy. The level of reassurance 
provided by midwives in these instances varied. Women’s concerns about using reflexology 
during pregnancy along with limited reassurance about the safety of using reflexology during 
pregnancy from some midwives could have been a contributory factor in the slow recruitment 
rates. Adopting a universal phrase about the safety of CAM in the pregnant population may 
have been helpful for ensuring women’s confidence in participation in a CAM trial. Indeed, 
several RCT’s investigating reflexology have been conducted on pregnant populations and no 
adverse effects have been reported. Maternity professionals must draw on high quality RCT or 
systematic review evidence (if available) when providing a statement about the safety of 
reflexology or other CAM treatments if questioned by prospective CAM trial participants [40, 41, 
42].  
In spite of the fact that some of the findings of this paper are focused on factors which negatively 
affect recruitment of pregnant women into trials, there were some findings from focus groups 
which highlighted factors which may positively facilitate recruitment into a CAM trials with 
pregnant women.  These included desire for pain relief in general and specifically pain relief 
that was non-pharmacological. These findings concur with research conducted by Maguire et 
al. [30] who explored decision making processes of pregnant women regarding participation in 
trials and also research by Wang et al. [31] who explored women’s preferences regards 
treatment for pregnancy low back pain. Researchers recruiting pregnant women into CAM trials 
may wish to make it clear that CAM is a non-pharmacological treatment as well as referring to 
available evidence related to its effectiveness and safety for pregnancy related symptoms for 
conditions like pregnancy LBPP. 
Attrition rates in the sham group were another major issue in The CAM in pregnancy Trial, with 
a 50% attrition rate in this group. High attrition rates in the footbath group indicate significant 
flaws in the study design [12]. The high attrition rates may be explained by women’s reported 
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hopes of getting randomised to the reflexology group. Several women in the usual care and 
footbath groups reported that the reason they dropped out of the trial was that they had not 
been randomised to receive reflexology. Attrition rates have been found to be problematic in 
previous CAM trials with pregnant . Mollart [6] had similar issues with drop outs in a single blind 
RCT investigating the effectiveness of two types of reflexology for ankle oedema compared 
with a rest control group. Seven of the 69 women randomised to the rest control group dropped 
out immediately after randomisation, three of whom stated their reason for dropping out was 
that ‘rest doesn’t work’.  The possible reason for high attrition rates in the present study and 
other similar CAM trials may be due to blinding issues. If participants are aware of which 
treatment is the treatment of interest for the study it is understandable that many would not wish 
to continue with the study if they realise that they have been randomised to a sham intervention.  
Blinding in the present study may not have been successful in many instances. Women’s 
comments suggested that they knew that reflexology was the treatment of interest. The un-
blinding of the study by midwives is understandable as reflexology is one of the CAM therapies 
most frequently offered in maternity units in the UK [35]. Furthermore, some of midwives in the 
ante-natal clinic where The CAM in Pregnancy Trial was conducted were reflexology trained 
themselves and it is probable that these midwives may have been over enthusiastic about the 
reflexology aspect of the research, inadvertently placing more emphasis on the reflexology 
when introducing the research to women.  
Limitations 
Only a small number of the women invited to participate in The CAM in Pregnancy Trial actually 
provided reasons for refusing to take part which reduces the external validity of the current 
results. This was a limitation in the research design as it was not part of the study protocol to 
ask women for a reason for their non-participation and as such the women who provided 
reasons for non-participation may differ from those who did not, thus raising questions about 
the representativeness of the sample. 
Conclusion 
General barriers identified to pregnant women’s participation in trials included timing of 
recruitment; competition for participants from other trials and inadequate trial promotion. 
Specific barriers to pregnant women’s participation in CAM trials included women’s perception 
of the risk of participation and limited support for maternity staff. Poor study blinding was likely 
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to be the major reason for the high attrition rates for the sham treatment group in the present 
trial. Researchers wishing to recruit pregnant women to trials and specifically CAM trials need 
to consider the barriers to recruitment and factors associated with high attrition identified in the 
present study and identify appropriate strategies to overcome these commonly occurring issues 
in CAM trials with pregnant women. Otherwise CAM trials with pregnant women will continue 
to be of poor quality and the evidence-base for CAM during pregnancy will remain sub-optimal.   
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